Search Results 1601-1610 of 16585 for Epilepsy (Partial Onset)

  1. Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 - Mayo Clinic

    randomization. 4. Have poorly controlled (> 1/week) generalized or complex partial seizures, or manifest neurologic progression due to brain lesions ...

  2. Multiscale EEG Dynamics - Clinical Trials

    Patients 1 day old and older with medically intractable partial or generalized epilepsy or facial pain who are undergoing clinical evaluation with the ...

  3. Neurological examinations - Care at Mayo Clinic

    Epilepsy. Stroke and aneurysms. Parkinson's disease and other movement disorders. Dementia and related conditions. Brain tumors and spinal cord tumors ...

  4. Neurosciences Clinical Trials - Medical Professionals

    Also, to investigate the effect of NBI-921352 on long-term seizure control. ... seizures in susceptible children by gaining a clearer understanding of the ...

  5. Neurosurgery - Doctors - Mayo Clinic

    ... epilepsy, Glioma-associated epilepsy. Show more areas of focus for Kaisorn L. Chaichana, M.D.. Selby G. Chen, M.D.. Neurosurgeon.

  6. Neurology - Clinical trials

    Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial ... epilepsy. Adipose- ...

  7. Neurology - Clinical trials

    Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial ... epilepsy. A ...

  8. Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) - Mayo Clinic

    The objective of Parts B and C of this study is to assess the effects of up to 24 weeks of pazopanib treatment on duration of epistaxis or level of serum ...

  9. Radiology - Clinical trials

    A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.

  10. A Study Of CAD106 And CNP520 Versus Placebo In Participants At Risk For The Onset Of Clinical Symptoms Of Alzheimer's Disease

    The purpose of this study is to test whether two investigational drugs called CAD106 and CNP520, administered separately, can slow down the onset and ...